Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 26, 2006, doi:10.1212/01.wnl.0000233834.09743.3b)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Polish Translation
Right arrow Turkish Translation
Right arrow All Versions of this Article:
01.wnl.0000233834.09743.3bv1
67/4/652    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Correale, J.
Right arrow Articles by Gilmore, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correale, J.
Right arrow Articles by Gilmore, W.
Related Collections
Right arrow All Infections
Right arrow Multiple sclerosis
NEUROLOGY 2006;67:652-659
© 2006 American Academy of Neurology

The risk of relapses in multiple sclerosis during systemic infections

Jorge Correale, MD, Marcela Fiol, MD and Wendy Gilmore, PhD

From the Department of Neurology (J.C., M.F.), Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina; and Departments of Neurology and Cell and Neurobiology (W.G.), Keck School of Medicine, University of Southern California, Los Angeles.

Address correspondence and reprint requests to Dr. Jorge Correale, Raúl Carrea Institute for Neurological Research, FLENI., Montañeses 2325, (1428) Buenos Aires, Argentina; e-mail: jcorreale{at}fleni.org.ar.

Objectives: To assess the risk of multiple sclerosis (MS) relapses, MRI activity, and T cell responses during systemic infections (SI) in patients with MS.

Methods: The authors prospectively studied 60 patients with MS. Twenty patients were evaluated with sequential MRI on initial visit, and 2 and 12 weeks later. Blood samples were collected at first infection symptom and 2, 5, 12, and 24 weeks later, and production of IL-4, IL-10, IL-12, IFN-{gamma}, TNF{alpha}, VLA-4, LFA-1, MMP-9, and MMP-2 were measured after infectious antigens (Ag) stimulation.

Results: Increased risk of relapse and MRI activity were observed during SI. Numbers of IFN-{gamma}, TNF{alpha}, and IL-12 secreting cells, serum concentrations of MMP-9, and expression of VLA-4 and LFA-1 after PBMC viral or bacterial Ag stimulation were higher in samples collected during exacerbations associated to SI. Transwell analysis demonstrated that soluble factors produced during viral stimulation have little effect on myelin specific T cells activity. In contrast, PBMC viral stimulation in the presence of cognate myelin Ag induces maximal effector responses at 20 to 30 times lower than the Ag alone.

Conclusions: There was a significant association between systemic infections and risk of MS relapse, increased MRI activity, and T cells activation. Furthermore, infectious agents increased myelin specific T-cells sensitivity to cognate Ag.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the August 22 issue to find the title link for this article.

This article was previously published in electronic format as an Expedited E-Pub on July 26, 2006, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

Received December 23, 2005.

Accepted in final form March 27, 2006.




This article has been cited by other articles:


Home page
BrainHome page
S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, and R. A. Du Pasquier
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Brain, July 1, 2008; 131(7): 1712 - 1721.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. Parratt, R. Tavendale, J. O'Riordan, D. Parratt, and R. Swingler
Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis
Multiple Sclerosis, April 1, 2008; 14(3): 292 - 299.
[Abstract] [PDF]


Home page
J. Immunol.Home page
V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. C. Gomez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, et al.
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
J. Immunol., April 1, 2008; 180(7): 4763 - 4773.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. A. Sobel
Anti-Viral T-Cell Immunity + Anti-CNS Autoantibody = A Model for Human Acute Disseminated Encephalomyelitis or Multiple Sclerosis Relapse?
Am. J. Pathol., February 1, 2007; 170(2): 436 - 438.
[Full Text] [PDF]


Home page
JWatch NeurologyHome page
Infections Increase the Risk for MS Relapses
Journal Watch Neurology, December 19, 2006; 2006(1219): 1 - 1.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.